Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

50,664 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Single-cell and spatial architecture of primary liver cancer.
Zhou PY, Zhou C, Gan W, Tang Z, Sun BY, Huang JL, Liu G, Liu WR, Tian MX, Jiang XF, Wang H, Tao CY, Fang Y, Qu WF, Huang R, Zhu GQ, Huang C, Fu XT, Ding ZB, Gao Q, Zhou J, Shi YH, Yi Y, Fan J, Qiu SJ. Zhou PY, et al. Among authors: zhou j, zhou c. Commun Biol. 2023 Nov 20;6(1):1181. doi: 10.1038/s42003-023-05455-0. Commun Biol. 2023. PMID: 37985711 Free PMC article.
Chemotherapeutic perfusion of portal vein after tumor thrombectomy and hepatectomy benefits patients with advanced hepatocellular carcinoma: A propensity score-matched survival analysis.
Gao Y, Wang PX, Cheng JW, Sun YF, Hu B, Guo W, Zhou KQ, Yin Y, Li YC, Wang J, Huang JF, Qiu SJ, Zhou J, Fan J, Yang XR. Gao Y, et al. Among authors: zhou kq, zhou j. Cancer Med. 2019 Nov;8(16):6933-6944. doi: 10.1002/cam4.2556. Epub 2019 Sep 30. Cancer Med. 2019. PMID: 31566899 Free PMC article.
Graft Programmed Death Ligand 1 Expression as a Marker for Transplant Rejection Following Anti-Programmed Death 1 Immunotherapy for Recurrent Liver Tumors.
Shi GM, Wang J, Huang XW, Huang XY, He YF, Ji Y, Chen Y, Wu D, Lu JC, Sun QM, Liu WR, Wang T, Yang LX, Hou YY, Shi YH, Sun J, Xiao YS, Wang Z, Fan J, Bertagnolli MM, Zhou J. Shi GM, et al. Among authors: zhou j. Liver Transpl. 2021 Feb;27(3):444-449. doi: 10.1002/lt.25887. Epub 2020 Dec 5. Liver Transpl. 2021. PMID: 32897657 No abstract available.
Dissecting spatial heterogeneity and the immune-evasion mechanism of CTCs by single-cell RNA-seq in hepatocellular carcinoma.
Sun YF, Wu L, Liu SP, Jiang MM, Hu B, Zhou KQ, Guo W, Xu Y, Zhong Y, Zhou XR, Zhang ZF, Liu G, Liu S, Shi YH, Ji Y, Du M, Li NN, Li GB, Zhao ZK, Huang XY, Xu LQ, Yu QC, Peng DH, Qiu SJ, Sun HC, Dean M, Wang XD, Chung WY, Dennison AR, Zhou J, Hou Y, Fan J, Yang XR. Sun YF, et al. Among authors: zhou kq, zhou j, zhou xr. Nat Commun. 2021 Jul 2;12(1):4091. doi: 10.1038/s41467-021-24386-0. Nat Commun. 2021. PMID: 34215748 Free PMC article.
Monocarboxylate transporter 4 inhibition potentiates hepatocellular carcinoma immunotherapy through enhancing T cell infiltration and immune attack.
Fang Y, Liu W, Tang Z, Ji X, Zhou Y, Song S, Tian M, Tao C, Huang R, Zhu G, Jiang X, Gao J, Qu W, Wang H, Zhou P, Wu X, Jin L, Sun H, Ding Z, Peng Y, Zhao S, Zhou J, Fan J, Xu W, Shi Y. Fang Y, et al. Among authors: zhou y, zhou j, zhou p. Hepatology. 2023 Jan 1;77(1):109-123. doi: 10.1002/hep.32348. Epub 2022 Feb 7. Hepatology. 2023. PMID: 35043976
Multiplexed nanomaterial-assisted laser desorption/ionization for pan-cancer diagnosis and classification.
Zhang H, Zhao L, Jiang J, Zheng J, Yang L, Li Y, Zhou J, Liu T, Xu J, Lou W, Yang W, Tan L, Liu W, Yu Y, Ji M, Xu Y, Lu Y, Li X, Liu Z, Tian R, Hu C, Zhang S, Hu Q, Deng Y, Ying H, Zhong S, Zhang X, Wang Y, Wang H, Bai J, Li X, Duan X. Zhang H, et al. Among authors: zhou j. Nat Commun. 2022 Feb 1;13(1):617. doi: 10.1038/s41467-021-26642-9. Nat Commun. 2022. PMID: 35105875 Free PMC article.
50,664 results
You have reached the last available page of results. Please see the User Guide for more information.